In addition, KIR/HLA compound genotype is associated with susceptibility to leukemia, cervical neoplasia, melanoma, and Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) [18–21, 26–33]. This evidence concerns the gene KIR3DL1 and leukemia.